文献
J-GLOBAL ID:201802263237206323
整理番号:18A0935409
第2線設定における悪性または難治性進行性非小細胞肺癌患者に対する抗血管新生療法【JST・京大機械翻訳】
Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting
著者 (14件):
Reck Martin
(Department of Thoracic Oncology, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Lung Clinic Grosshansdorf, Grosshansdorf, Germany)
,
Garassino Marina Chiara
(Fondazione IRCCS Istituto Nazionale dei Tumori, Division of Medical Oncology, Milano, Italy)
,
Imbimbo Martina
(Fondazione IRCCS Istituto Nazionale dei Tumori, Division of Medical Oncology, Milano, Italy)
,
Shepherd Frances A.
(Princess Margaret Cancer Centre, Toronto, Ontario, Canada)
,
Socinski Mark A.
(Thoracic Oncology Program, Florida Hospital Cancer Institute, Orlando, FL, USA)
,
Shih Jin-Yuan
(National Taiwan University Hospital, Taipei, Taiwan)
,
Tsao Anne
(University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Lee Pablo
(Eli Lilly and Company, Bridgewater, NJ, USA)
,
Winfree Katherine B.
(Eli Lilly and Company, Indianapolis, IN, USA)
,
Sashegyi Andreas
(Eli Lilly and Company, Indianapolis, IN, USA)
,
Cheng Rebecca
(Eli Lilly and Company, Taipei, Taiwan)
,
Varea Rocio
(Eli Lilly and Company, Madrid, Spain)
,
Levy Benjamin
(Johns Hopkins University, Baltimore, MD, USA)
,
Garon Edward
(David Geffen School of Medicine at UCLA/Translational Research in Oncology-US Network, Los Angeles, CA, USA)
資料名:
Lung Cancer
(Lung Cancer)
巻:
120
ページ:
62-69
発行年:
2018年
JST資料番号:
W3184A
ISSN:
0169-5002
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)